The Glucosamine Supplements Market is to Touch $5.6 Billion by 2030; rising awareness of joint health benefits and increasing demand for natural supplements propel market growth.

The Glucosamine Supplements Market size is estimated to reach $5.6 billion by 2030, growing at a CAGR of 6.6% during the forecast period 2024-2030, according to a recent report published by IndustryARC, titled, “Glucosamine Supplements Market – By Presentation (Liquids, Capsules, Tablets, Powder, Others), By Application (Food and Beverages, Medicines, Protein Supplements and Powders, Dairy Products, Cosmetics, Others), By Forms (Glucosamine sulfate, Glucosamine HCL, N-acetyl glucosamine), By Distributional Channel (Hospitals, Local medical stores, Drug stores, retail Pharmacies, Online), By Geography - Global Opportunity Analysis & Industry Forecast, 2024-2030”

Growing consumer preference for preventive healthcare and expanding geriatric population are fueling the growth of the Glucosamine Supplements industry during the forecast period.

In 2023, North America accounted for the largest share of the Glucosamine Supplements market at 40%. This growth is attributed to factors such as an expanding elderly population, which has led to an increased prevalence of joint disorders, glaucoma, rheumatoid arthritis, and other age-related complications. The region benefits from an advanced healthcare infrastructure and widespread distribution channels, ensuring accessibility to these supplements. As the aging population grows, chronic conditions associated with aging, like osteoarthritis, are becoming more frequent, further driving demand for glucosamine supplements. The expanding presence of retail and online platforms has also contributed to the market’s robust growth, allowing for greater product visibility and consumer reach. These factors collectively position North America as a key player in the market’s expansion. 

The rapid increase in the global elderly population is projected to drive market growth significantly. Over the past decade, the percentage of individuals aged 65 and above has risen from 8.5% to 10%, and this figure is expected to reach 13-14% in the coming years. Age-related conditions, such as osteoarthritis and Kashin-Beck disease, are becoming more common as the population ages, leading to a growing demand for glucosamine supplements. These supplements are increasingly sought after for their ability to alleviate joint pain and improve mobility in aging individuals. As health awareness rises globally, the use of glucosamine for managing conditions like back pain and joint stiffness is expected to see continued growth, further boosting the market.

The high effectiveness of glucosamine supplements is a key driver for product demand. Glucosamine Hydrochloride (HCl) is widely recognized for its benefits in treating various conditions, from glaucoma to rheumatoid arthritis, making it a popular choice among consumers. Additionally, its use extends to managing high cholesterol levels, a condition affecting nearly 94 million adults in the U.S. with cholesterol levels above 200 mg/dL. Beyond its therapeutic applications, glucosamine is also used in the production of protein supplements, powders, and beverages, appealing to health-conscious consumers. As the trend toward preventive healthcare and wellness continues to grow, glucosamine supplements are gaining traction as a versatile solution for multiple health concerns, reinforcing their demand.